Kenya tackles drug-resistant TB with new treatment regimens
Kenya has made substantial advancements in tackling drug-resistant TB (DR-TB), with 750 patients started on second-line treatment. The introduction of shorter, patient-friendly regimens for multidrug-resistant TB (MDR-TB) and rifampicin-resistant TB (RR-TB)
Read on